APJO COVID-19 FAQs

List of Contents

• Home (Latest Statistics)
• 1. Chronological development of COVID-19
• 2. SARS-CoV-2
  • 2.1 The coronaviruses
  • 2.2 SARS-CoV-2 vs SARS-CoV vs MERS-CoV
• 3. COVID-19
  • 3.1 Main symptoms of COVID-19
  • 3.2 High infectivity (Why is COVID-19 so infectious?)
  • 3.3 Case fatality rate (CFR) & risk factors
  • 3.4 Anti-COVID drugs
• 4. Modes of transmission
  • 4.1 Droplets & aerosols
  • 4.2 Modes of transmission
  • 4.3 Survival time of SARS-CoV-2
• 5. Preventing COVID-19
  • 5.1 Social distancing
  • 5.2 Respiratory hygiene
  • 5.3 Hand hygiene
  • 5.4. Applying technology in COVID-19
• 6. Sharing from patients and health care workers
  • 6.1 Sharing from patients
  • 6.2 Sharing from medical and health care workers
• 7. Ophthalmic practice: special precautions
• 8. Global & national challenges & responses
  • 8.1 WHO
  • 8.2 Herd immunity
  • 8.3 Policy speeches from high government officials
  • 8.4 Testing
  • 8.5 Personal protective equipment (PPE)
  • 8.6 Social distancing
  • 8.7 Lockdown
• 9. Humanity & arts
• 10. Socio-cultural & economic impact of COVID-19
  • 10.1 Economic & financial impact
  • 10.2 Psychology & society stress
  • 10.3 Societal & cultural impact
• 11. Origin of the virus
• 12. Vaccine
• About Us